Myelodysplastic Syndromes D009190

Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Bone Marrow Diseases » Myelodysplastic Syndromes

Description

Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.   MeSH

Subtype Terms (4)

Anemia, Refractory
62 drugs (35 approved, 27 experimental)

Anemia, Sideroblastic
 

GATA2 Deficiency
10 drugs (8 approved, 2 experimental)

Hemoglobinuria, Paroxysmal
46 drugs (23 approved, 23 experimental)


Phase 3 Indicated Drugs (95)

Phase 2 Indicated Drugs (243)

Phase 1 Indicated Drugs (195)


Organization Involved with Phase 3 Indications (138)

Organization Involved with Phase 2 Indications (289)

Aalborg University

Aarhus University

ADC Therapeutics SARL

ALX Oncology

Alza

Ambit Biosciences

AnorMED

argenx

Ariad Pharmaceuticals

Arno Therapeutics

Asociación Andaluza de Hematología y Hemoterapia

Assisi Foundation

Associazione Qol-one

Azienda Ospedaliera Antonio Cardarelli

Bambino Gesù Hospital and Research Institute

Bar Ilan University

Baylor University

BerGenBio ASA

BioLineRx, Ltd.

BioLite, Inc.

BioMAS Ltd

BioMed Valley Discoveries, Inc

Bio-Path Holdings, Inc.

Biosuccess Biotech Co., Ltd.

Boehringer Ingelheim

Bristol-Myers Squibb

Calithera Biosciences

Cancer Biotherapy Research Group

Cancer Treatment Centers of America

Catholic University of Korea

Cedars-Sinai Medical Center

Celator Pharmaceuticals

Celerion

Celldex Therapeutics

Cellectar, Inc

Cellerant Therapeutics

Cellphire, Inc.

Cell Therapy Catapult

Cell Therapy Transplant Canada

Cephalon

Chao Family Comprehensive Cancer Center

Children's Hospital Los Angeles

Chiltern International

Chonbuk National University

Chonnam National University

Chroma Therapeutics

Chu De Liège

CHU Mont-Godinne

Chung-Ang University

City of Hope National Medical Center

Ciusss de L'Est de l'Île de Montréal

ClinAssess GmbH

Colorado Blood Cancer Institute

Columbia University

Cookies for Kids' Cancer

CrystalGenomics, Inc.

CTC Bio, Inc.

CTI BioPharma

Curie Institute

Cyclacel Pharmaceuticals, Inc.

Daegu Catholic University

Department of Health and Human Services

Department of Health, United Kingdom

Department of Veteran Affairs

DKMS Stiftung Leben Spenden

Doris Duke Charitable Foundation

Drexel University

Duke University

Ellipses Pharma

Emory University

EpiCept Corporation

European Group for Blood and Marrow Transplantation

Ewha Womans University

ExcellThera

Fate Therapeutics

Fondation ARC

Food and Drug Administration

Forma Therapeutics, Inc.

Fortress Biotech

Free University of Amsterdam

Free University of Brussels

Fujifilm

Fundacion para el Estudio de la Hematologia y Hemoterapia en Aragon

Gachon University

Gemin X

Genentech

Genzyme

German Research Foundation

Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH

Ghent University

GlaxoSmithKline

Good Samaritan Hospital, Cincinnati

Government of Italy

Government of Singapore

Government of Spain

GWT-TUD GmbH

Helsinn

Herbert Irving Comprehensive Cancer Center

Hoag Memorial Hospital Presbyterian

Hoosier Cancer Research Network

Hopital de l'Enfant-Jesus

Hôpital Saint Louis

Humanigen

Humboldt University

IGF Oncology, LLC

Immune System Key Ltd

Imperial College London

INC Research

Incyte

Inha University

Inje University

Inner Mongolia International Mongolian Hospital

Institut Paoli-Calmettes

Janssen Pharmaceutica NV

Jazz Pharmaceuticals

Jilin University

Jin Yang Pharmaceutical

Johann Wolfgang Goethe University Hospital

Julius-Maximilians University

Karolinska Institute

Karyopharm Therapeutics Inc

Keimyung University

Keio University

Keros Therapeutics

Korea Research Institute of Bioscience & Biotechnology

Korea University

Kura Oncology, Inc.

Kyowa Hakko Kirin

Leiden University

Lixte Biotechnology Holdings, Inc.

Louis A. Weiss Memorial Hospital

Lundbeck

Lund University

Mateon Therapeutics

McGill University

McMaster University

MDS Consortium

Medical University Innsbruck

Medical University of South Carolina

MedPacto, Inc.

MEI Pharma

Memorial Sloan-Kettering Cancer Center

Mesoblast, Inc.

Methodist Cancer Center, Houston, Texas

MethylGene Inc.

Miltenyi Biotec, Inc.

Mirati Therapeutics Inc.

Moorgreen Hospital, Southampton

National Cancer Institute, France

National Institute of Allergy and Infectious Diseases (NIAID)

National Institutes of Health (NIH)

New York Medical College

New York Presbyterian Hospital

New York University

NexImmune Inc.

Nordic MDS Group

North Central Cancer Treatment Group

Northside Hospital, Inc.

Novacea

OHSU Knight Cancer Institute

Oncoceutics, Inc.

Oncology Specialties, Alabama

Oncology Specialties, PC

OncoTherapy Science, Inc.

Onyx

Opsona Therapeutics Ltd.

Ortho Biotech, Inc.

Otsuka

Our Lady of Mercy Medical Center

Ozmosis Research Inc.

Parexel

Paris Diderot University

Pavlov First Saint Petersburg State Medical University

Pediatric Brain Tumor Consortium

Peking University

Pennsylvania State University

Peter MacCallum Cancer Centre

Pfizer

Polyphor Ltd.

Providence Hospital

Pusan National University

QOL-ONE Associazione Culturale e di Ricerca

Rafael Pharmaceuticals Inc.

Reliant Medical Group

Rockefeller University

Rush University

Sangstat Medical Corporation

S*BIO

Scios

Sclnow Biotechnology Co., Ltd.

SCRI Development Innovations

Seattle Genetics

Sensei Pharmaceuticals, Inc.

Seoul National University

service Hématologie Séniors Hôpital Saint Louis

Shandong University

Sheba Medical Center

Sheffield Hallam University

Singapore General Hospital

Soonchunhyang University

Sponsor GmbH

Stanford University

State of Texas

St. Baldrick's Foundation

Stem Cell Network

Sumitomo Dainippon

Sunesis Pharmaceuticals

Sungkyunkwan University

Sutter Health

Swedish Orphan Biovitrum

Syros Pharmaceuticals

Takeda

Targazyme, Inc.

Technical University of Denmark

Telik

TetraLogic Pharmaceuticals

Texas Oncology Cancer Center

The Cleveland Clinic

The Korean Society of Blood and Marrow Transplantation

The University of Texas, Dallas

The Vaccine Company

The Wayne D. Kuni and Joan E. Kuni Foundation

Thomas Jefferson University

Tokyo Metropolitan Komagome Hospital

Tolero Pharmaceuticals

Universita' Cattolica del Sacro Cuore

Universitair Ziekenhuis Gent

Université catholique de Louvain

University Hospital of Mont-Godinne

University of Alabama, Birmingham

University of Antwerp

University of Bergen

University of Bern

University of Bologna

University of Bordeaux

University of Brescia

University of California, Davis

University of California, San Diego

University of California, San Francisco

University of Campinas

University of Chicago

University of Cincinnati

University of Colorado, Denver

University of Copenhagen

University of Duesseldorf

University of Erlangen-Nuremberg

University of Florida

University of Genoa

University of Gothenburg

University of Hamburg

University of Helsinki

University of Illinois at Chicago

University of Kentucky

University of Leeds

University of Lille

University of Medicine and Dentistry of New Jersey

University of Miami

University of Minnesota

University of Nantes

University of Nebraska

University of New Mexico

University of Nice Sophia Antipolis

University of North Carolina at Chapel Hill

University of Oslo

University of Paris

University of Regensburg

University of Rochester

University of Siena

University of South Carolina

University of Southern California

University of Southern Denmark

University of Sussex

University of Toulouse

University of Udine

University of Ulm

University of Utah

University of Wisconsin

Van Andel Research Institute

Veeda Clinical Research

Vical

Vion Pharmaceuticals

Vita-Salute University of Milano. Italy

Wake Forest University

Washington University in St. Louis

Yale University

Yeshiva University

Yonsei University

Yukiguni Maitake Company Ltd.

ZNA Antwerpen

Organization Involved with Phase 1 Indications (95)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.